Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.
A California judge on Friday tossed a jury award of $417 million from Johnson & Johnson to a woman who claimed the company's baby powder gave her ovarian cancer, finding the plaintiff relied on speculative expert testimony that failed to link talcum powder to cancer.
An Illinois federal judge on Friday denied a bid by Abbott Laboratories to toss a suit alleging it failed to properly warn doctors about the risk of birth defects like spina bifida from the use of Depakote, rejecting the drugmaker's assertion that merely listing the probability of the defect on the drug's label was sufficient under Maryland law.
German drugmaker Boehringer Ingelheim Pharmaceuticals Inc. filed a pair of patent infringement suits Friday in New Jersey federal court over bids by Sandoz Inc. and Sun Pharmaceutical Industries to market generic versions of its cancer therapy drug.
If Johnson & Johnson’s talcum powder products contained asbestos, a person using them on their child or on themselves could develop mesothelioma, a former Tulane pathology professor and asbestos expert testified in a California trial Friday for a woman alleging she developed the cancer in this way.
State attorneys general, a Native American tribe and individual consumers are among the chorus of plaintiffs who've brought lawsuits against drugmakers, pharmacies and distributors allegedly responsible for epidemic levels of opioid abuse. Here, Law360 gives an overview of major pending opioid cases and how far they've progressed.